Bal Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 25, 2016, to take on record and approve the audited financial results of the Company for the financial year ended March 31, 2016; Appropriation of profits including recommendation of dividend, if any for the F.Y 2015-16; to consider various other A.G.M related aspects. As per the provisions of Bal Pharma Code of Conduct for prevention of insider trading, the trading window of the Company shall remain closed on all the specified persons of the Company, from May 13, 2016 and up to May 28, 2016.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.70 |
| Dr. Reddys Lab | 1220.00 |
| Cipla | 1232.60 |
| Zydus Lifesciences | 928.05 |
| Lupin | 2305.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: